Thursday 6 October 2022 02:25 PM US buys $290m worth of radiation sickness drugs amid Russia's nuclear threat trends now
View
comments
The US has stocked up on radiation sickness drugs just weeks after Vladimir Putin threatened to use nuclear weapons against the West.
Officials said the deal — worth $290million — was ‘part of ongoing work’ and ‘has not been accelerated’ by the Kremlin leader's escalating rhetoric.
The US Health and Human Services (HHS) - whose motto is to 'improve the health, safety, and well-being of America - announced the purchase of romiplostim Tuesday.
Sold under the brand name Nplate, it is used to reduce bleeding caused by acute radiation syndrome (ARS), also known as radiation sickness.
Putin issued a chilling warning late last month that he was prepared to use Russia’s nuclear arsenal to protect Ukrainian territory annexed after sham referendums.
But the US Health and Human Services (HHS) said the drug order was ‘part of ongoing work’ and ‘has not been accelerated’ by Putin’s warning.
However, the timing will likely raise questions given that this is the first time the US Government has bought Nplate.
The US Government began stocking up on anti-radiation drug Nplate after Vladimir Putin threatened to nuke the West over Ukraine